United States · FDA National Drug Code directory
Levbid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68220-115_bd220cfd-9d8c-4aea-812e-92c0774f1c91
- Product NDC
- 68220-115
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- hyoscyamine sulfate
- Labeler
- Viatris Specialty LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20081201
- Source listing expiry
- 20271231
Source-listed ingredients
- HYOSCYAMINE SULFATE — .375 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TABLET, EXTENDED RELEASE in 1 BOTTLE (68220-115-10) · 68220-115-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →